Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Risk of End-stage Renal Disease in Patients with Lupus Nephritis, 1970 to 2015 A systematic review and Bayesian meta-analysis.

Tektonidou MG, Dasgupta A, Ward MM.

Arthritis Rheumatol. 2016 Jan 27. doi: 10.1002/art.39594. [Epub ahead of print]

PMID:
26815601
2.

A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial.

Tamirou F, Lauwerys BR, Dall'Era M, Mackay M, Rovin B, Cervera R, Houssiau FA; MAINTAIN Nephritis Trial Investigators.

Lupus Sci Med. 2015 Nov 12;2(1):e000123. doi: 10.1136/lupus-2015-000123. eCollection 2015.

3.

Cardiac involvement in antiphospholipid syndrome: The diagnostic role of noninvasive cardiac imaging.

Mavrogeni SI, Sfikakis PP, Kitas GD, Kolovou G, Tektonidou MG.

Semin Arthritis Rheum. 2015 Oct 8. pii: S0049-0172(15)00234-6. doi: 10.1016/j.semarthrit.2015.09.005. [Epub ahead of print] Review.

PMID:
26616201
4.

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.

Tamirou F, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, Houssiau FA; MAINTAIN Nephritis Trial Group.

Ann Rheum Dis. 2016 Mar;75(3):526-31. doi: 10.1136/annrheumdis-2014-206897. Epub 2015 Mar 10.

5.

Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011.

Tektonidou MG, Wang Z, Dasgupta A, Ward MM.

Arthritis Care Res (Hoboken). 2015 Aug;67(8):1078-85. doi: 10.1002/acr.22575.

PMID:
25732901
6.

The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.

Abreu MM, Danowski A, Wahl DG, Amigo MC, Tektonidou M, Pacheco MS, Fleming N, Domingues V, Sciascia S, Lyra JO, Petri M, Khamashta M, Levy RA.

Autoimmun Rev. 2015 May;14(5):401-14. doi: 10.1016/j.autrev.2015.01.002. Epub 2015 Jan 29. Review.

PMID:
25641203
7.

Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.

Arnaud L, Mathian A, Devilliers H, Ruffatti A, Tektonidou M, Forastiero R, Pengo V, Lambert M, Lefevre G, Martinez-Zamora MA, Balasch J, Wahl D, Amoura Z.

Autoimmun Rev. 2015 Mar;14(3):192-200. doi: 10.1016/j.autrev.2014.10.019. Epub 2014 Oct 22. Review.

PMID:
25461472
8.

Women's health and fertility, family planning and pregnancy in immune-mediated rheumatic diseases: a report from a south-eastern European Expert Meeting.

Ntali S, Damjanov N, Drakakis P, Ionescu R, Kalinova D, Rashkov R, Malamitsi-Puchner A, Mantzaris G, Michala L, Pamfil C, Rednic S, Tektonidou MG, Tsiodras S, Vassilopoulos D, Vojinovic J, Bertsias GK, Boumpas DT.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):959-68. Epub 2014 Nov 7. Review.

PMID:
25436516
9.

Asymptomatic bacteriuria in women with autoimmune rheumatic disease: prevalence, risk factors, and clinical significance.

Georgiadou SP, Gamaletsou MN, Mpanaka I, Vlachou A, Goules AV, Ziogas DC, Syriou V, Tektonidou MG, Kaltsas G, Manoussakis MN, Sipsas NV.

Clin Infect Dis. 2015 Mar 15;60(6):868-74. doi: 10.1093/cid/ciu938. Epub 2014 Nov 24.

PMID:
25422387
10.

Identification and treatment of APS renal involvement.

Tektonidou MG.

Lupus. 2014 Oct;23(12):1276-8. doi: 10.1177/0961203314538687.

PMID:
25228725
11.

14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.

Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A, Levy RA, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Willis R, Lockshin MD.

Autoimmun Rev. 2014 Jun;13(6):685-96. doi: 10.1016/j.autrev.2014.01.053. Epub 2014 Jan 24. Review.

PMID:
24468415
12.

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).

Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24.

PMID:
24464962
13.

Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis.

Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R, Forastiero R, Pengo V, Lambert M, Martinez-Zamora MA, Balasch J, Zuily S, Wahl D, Amoura Z.

Autoimmun Rev. 2014 Mar;13(3):281-91. doi: 10.1016/j.autrev.2013.10.014. Epub 2013 Nov 2. Review.

PMID:
24189281
14.

Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".

Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE, Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G; Catastrophic Registry Project Group (European Forum on Antiphospholipid Antibodies).

Autoimmun Rev. 2014 Feb;13(2):157-62. doi: 10.1016/j.autrev.2013.10.004. Epub 2013 Oct 19.

PMID:
24145009
15.

Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).

Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L, Gordon C, Ruiz-Irastorza G, Egurbide MV, Gil A, Espinosa G, Houssiau F, Rahman A, Martin H, McHugh N, Galindo M, Akil M, Amigo MC, Murru V, Khamashta MA.

Rheumatology (Oxford). 2014 Feb;53(2):275-84. doi: 10.1093/rheumatology/ket313. Epub 2013 Oct 4.

16.

Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.

Kampolis C, Tektonidou M, Moyssakis I, Tzelepis GE, Moutsopoulos H, Vlachoyiannopoulos PG.

Semin Arthritis Rheum. 2014 Feb;43(4):558-65. doi: 10.1016/j.semarthrit.2013.07.016. Epub 2013 Sep 5.

PMID:
24012042
17.

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.

Berman H, Rodríguez-Pintó I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan D, Shoenfeld Y, Espinosa G; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies).

Autoimmun Rev. 2013 Sep;12(11):1085-90. doi: 10.1016/j.autrev.2013.05.004. Epub 2013 Jun 15.

PMID:
23777822
18.

Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis.

Konsta M, Bamias G, Tektonidou MG, Christopoulos P, Iliopoulos A, Sfikakis PP.

Rheumatology (Oxford). 2013 Mar;52(3):448-51. doi: 10.1093/rheumatology/kes316. Epub 2012 Nov 30.

19.

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association.

Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.

20.

Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.

Espinosa G, Rodríguez-Pintó I, Gomez-Puerta JA, Pons-Estel G, Cervera R; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies).

Semin Arthritis Rheum. 2013 Feb;42(4):417-23. doi: 10.1016/j.semarthrit.2012.05.005. Epub 2012 Jul 10.

PMID:
22784445
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk